Upfront Therapy for Non‑transplantable Multiple Myeloma in 2026: Decision‑making in an Increasingly Complex Therapeutic Landscape. Can Hematol Today 2026, 5 (1), 24–35. https://doi.org/10.58931/cht.2026.5185.